gc 1 peptide a thyromimetic drug that binds to the thyroid hormone receptor TRβ1 preferentially

Dr. Brian Lopez logo
Dr. Brian Lopez

gc 1 peptide GC - GC-1peptidebenefits Peptide Unveiling the Potential of GC-1 Peptide: A Deep Dive into its Thyroid Hormone Receptor Agonist Properties

GC-1 sobetirome results The GC-1 peptide, more commonly known by its chemical name Sobetirome, has emerged as a significant area of research within the scientific community. This synthetic compound acts as a potent and selective agonist for the thyroid hormone receptor beta (TRβ), mimicking the actions of natural thyroid hormones.Sobetirome (GC-1, QRX431) is a potent and selective agonist of thyroid hormone receptor β (TRβ) , with an EC50 of 0.16 μM for TRβ-1. It is used in re. Its unique biochemical profile and receptor selectivity have positioned Sobetirome (GC-1) as a compound with considerable therapeutic potential, particularly in areas related to metabolism and obesity.

Understanding the Mechanism of GC-1 Peptide

At its core, GC-1 is a thyromimetic drug. This means it imitates the effects of thyroid hormones.GC-1not only prevented steatosis in rodents but also induced a marked reduction of preaccumulated fat without significant side effects on heart rate [98,99]. Specifically, it exhibits high affinity for thyroid hormone receptors, with reported KD values of 67 pM for the human TRβ1 receptor and 440 pM for the TRα1 receptor.作者:X Chu·2025—A new efficient synthesis of TRβ-selective thyromimeticGC-1is described. The present strategy employs benzyl substituent as the exclusive ... This preferential binding to TRβ1 is crucial, as it allows for targeted effects with potentially fewer side effects compared to non-selective thyroid hormone mimetics. The EC50 for TRβ-1 binding is reported as 0.16 µM, underscoring its potent agonist activity.

Therapeutic Applications and Research Findings

The research surrounding GC-1 peptide has highlighted several promising therapeutic applications. Studies have indicated its potential in treating obesity and metabolic syndrome. In rodent models, GC-1 has demonstrated the ability to prevent steatosis (fatty liver disease) and significantly reduce accumulated fat without causing adverse effects on heart rate, a common concern with other thyroid-related compounds. Furthermore, GC-1 has been observed to dramatically increase metabolic rate, effectively converting "bad" white fat, which stores excess calories, into "good" brown fat. This conversion process is linked to enhanced energy expenditure.

Beyond fat metabolism, research has explored the impact of Sobetirome on other physiological processes. Studies have shown that GC-1 can lower cholesterol levels with remarkable potency and efficacy compared to other agents. Its influence extends to bile acid (BA) metabolism, suggesting a broader role in lipid regulation作者:E Rinaldini·2021·被引用次数:2—This study aims to demonstrate TH-selective signaling effects on reproductive and lactational performance in hypothyroid rats.. There is also evidence suggesting GC-1 can induce hepatocyte proliferation, a process relevant to liver health and repair.

The selective signaling of thyroid hormone receptor beta by GC-1 is also being investigated for its effects on reproductive and lactational performance, particularly in hypothyroid models. This points to a nuanced understanding of how Sobetirome can modulate specific thyroid hormone signaling pathways.Gc-1 Sobetirome

Availability and Synthesis

For researchers and those interested in exploring the properties of GC-1, it is available from various suppliers, often listed under its alternative name, SobetiromeActivating thyroid hormone receptor may rev up metabolism. The compound is typically stored lyophilized at -20°C and requires desiccation. Efforts have been made to develop improved and efficient synthesis methods for TRβ-selective thyromimetic GC-1, indicating ongoing advancements in its productionSobetirome - Thyroid Hormone Receptor Agonist. While GC-1 is often discussed in the context of peptides due to its molecular nature and the way it interacts with receptors, it is important to distinguish it from other types of peptides such as collagen peptides which might be used for different health benefits like boosting GLP-1 production.

Important Considerations and Future Directions

While the research on GC-1 peptide is highly encouraging, it is crucial to acknowledge that much of the current understanding stems from preclinical studies. Further investigation is required to fully elucidate its long-term effects, optimal GC-1 sobetirome dosage, and potential GC-1 sobetirome side effects in human subjects.Rousselot's Nextida GC collagen peptides boosts GLP-1 ... The scientific community continues to explore the past, present, and future of Sobetirome, aiming to harness its full therapeutic potential for a range of conditions. The exploration of GC 1 and its impact on metabolic pathways remains a dynamic and evolving field of scientific inquiry.

Log In

Sign Up
Reset Password
Subscribe to Newsletter

Join the newsletter to receive news, updates, new products and freebies in your inbox.